BiologicalDrug
Rabies virus strain flury LEP antigen (propiolactone inactivated) clinical trials
Also written RabAvert and Rabipur.
- studies test it
- 10
- open now
- 0
- in phase 3
- 2
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 6
U.S. Army Medical Research and Development Command (2) · Centers for Disease Control and Prevention (1) · London School of Hygiene and Tropical Medicine (1) · Kamada, Ltd. (1) · Synermore Biologics Co., Ltd. (1) · CureVac (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1)
Often tested with
Tested in the same studies.
SYN023 (1) · Rabies virus strain PM-1503-3M antigen (propiolactone inactivated) (1) · CV-8102 (1) · Pneumococcal Vaccines (1) · Heptavalent Pneumococcal Conjugate Vaccine (1)
Studies
Open first, then newest update. How each study uses rabies virus strain flury LEP antigen (propiolactone inactivated) is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study of Intradermal Administration of PCEC Rabies VaccineCompletedNot applicableCenters for Disease Control and PreventionNCT01044199Written as PCEC rabies vaccine given intradermally
- Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01BCompletedPhase 1U.S. Army Medical Research and Development CommandNCT02458092Written as Rabipur
- Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)CompletedPhase 3London School of Hygiene and Tropical MedicineNCT03143218Written as RABIPUR®
- Non Inferiority Trial of Locally Manufactured Rabies Vaccine 'Rabix-VC' in BangladeshStatus unknownPhase 1International Centre for Diarrhoeal Disease Research, BangladeshNCT04715867Written as Rabix-VC
- Antibody Production in Immune DisordersTerminatedPhase 4National Institute of Allergy and Infectious Diseases (NIAID)NCT00023504Written as Rabavert
- Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy SubjectsCompletedPhase 2/3Kamada, Ltd.NCT02040090Written as Active rabies vaccine (US-FDA approved)
- A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies VaccinesCompletedPhase 1/2Synermore Biologics Co., Ltd.NCT02956746Written as RabAvert
- Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy AdultsCompletedPhase 1CureVacNCT02238756Written as Rabipur
- A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese ChildrenWithdrawnPhase 4GlaxoSmithKlineNCT03192371Written as Rabipur
- Phase I Pediatric FMP2.1/AS02A Trial in MaliCompletedPhase 1U.S. Army Medical Research and Development CommandNCT00358332Written as Rabies vaccine (RabAvert)
Given in every arm · 3 — rabies virus strain flury LEP antigen (propiolactone inactivated) is usual care beside what is tested
- Washington University WU 409: Immune Responses to Rabies Vaccine.CompletedEarly Phase 1Washington University School of MedicineNCT07399951Written as RabAvert
- A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.CompletedPhase 3GlaxoSmithKlineNCT02545517Written as Rabipur
- Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy SubjectsCompletedPhase 2/3Bio Products LaboratoryNCT03264157Written as RabAvert
As the comparator · 8 — what is tested is compared with rabies virus strain flury LEP antigen (propiolactone inactivated)
- A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy AdultsCompletedPhase 1CureVacNCT03713086Written as Rabipur®
- A Study of RBI-4000 in Healthy ParticipantsTerminatedPhase 1Replicate BioscienceNCT06048770Written as RabAvert
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy AdultsCompletedPhase 1GlaxoSmithKlineNCT04062669Written as RabAvert
- Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria VaccineCompletedPhase 2U.S. Army Medical Research and Development CommandNCT00223990Written as RabAvert
- Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian ChildrenCompletedPhase 2GlaxoSmithKlineNCT00360230Written as Rabipur
- FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, MaliCompletedPhase 1U.S. Army Medical Research and Development CommandNCT00349713Written as Rabies vaccine (RabAvert)
- Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated RegimenCompletedPhase 2Yisheng Biopharma (Singapore) Pte. Ltd.NCT02956421Written as RABIPUR®
- Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA AdjuvantCompletedPhase 1Yisheng Biopharma (Singapore) Pte. Ltd.NCT02657161Written as RABIPUR®
Codes
What other systems call rabies virus strain flury LEP antigen (propiolactone inactivated) · ClinicalTrials.gg INT016568
- UNII (FDA) FK894Q51YERABIES VIRUS STRAIN FLURY LEP ANTIGEN (PROPIOLACTONE INACTIVATED)One source FDA
- RxNorm 830457One source FDA
- NCI Thesaurus C75812Rabies Virus Strain Flury LEP Antigen (Propiolactone Inactivated)One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | FK894Q51YE | RABIES VIRUS STRAIN FLURY LEP ANTIGEN (PROPIOLACTONE INACTIVATED) | One source FDA |
| RxNorm | 830457 | — | One source FDA |
| NCI Thesaurus | C75812 | Rabies Virus Strain Flury LEP Antigen (Propiolactone Inactivated) | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.